Methylation Changes Do Not Cause PTTG1 Over-Expression
Author Information
Author(s): Hidalgo Manuel, Galan Jose Jorge, Sáez Carmen, Ferrero Eduardo, Castilla Carolina, Ramirez-Lorca Reposo, Pelaez Pablo, Ruiz Agustin, Japón Miguel A, Royo Jose Luis
Primary Institution: Hospital Universitario 12 de Octubre, Madrid, Spain
Hypothesis
Can methylation alterations explain the over-expression of PTTG1 in tumors?
Conclusion
The study found that neither methylation alterations nor loss of heterozygosity are responsible for PTTG1 over-expression.
Supporting Evidence
- PTTG1 is over-expressed in various tumors and linked to poor prognosis.
- Previous studies suggested that promoter mutations do not significantly affect PTTG1 expression.
- PTTG1 expression levels were not correlated with methylation status in tumor samples.
Takeaway
The study looked at a protein called PTTG1 that is linked to cancer, and found that changes in DNA methylation don't cause it to be over-produced in tumors.
Methodology
The study analyzed PTTG1 expression in tumor cell lines and biopsies, using methylation-specific PCR and whole-genome LOH studies.
Limitations
The study did not explore other potential epigenetic mechanisms that could affect PTTG1 expression.
Participant Demographics
Participants included 47 individuals with differentiated thyroid carcinoma and 185 controls from the Spanish population.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website